These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34228437)

  • 21. Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
    Prasad K; Ahamad S; Kanipakam H; Gupta D; Kumar V
    ACS Chem Neurosci; 2021 Mar; 12(5):930-944. PubMed ID: 33606519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ravaging SARS-CoV-2: rudimentary diagnosis and puzzling immunological responses.
    Mukherjee TK; Malik P; Maitra R; Hoidal JR
    Curr Med Res Opin; 2021 Feb; 37(2):207-217. PubMed ID: 33306409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.
    Mudgal R; Nehul S; Tomar S
    Hum Vaccin Immunother; 2020 Dec; 16(12):2921-2931. PubMed ID: 32931361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.
    Ricke DO
    Front Immunol; 2021; 12():640093. PubMed ID: 33717193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19.
    Alipour S; Mahmoudi L; Ahmadi F
    Drug Deliv Transl Res; 2023 Mar; 13(3):705-715. PubMed ID: 36260223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2.
    Peele KA; Kumar V; Parate S; Srirama K; Lee KW; Venkateswarulu TC
    J Pharm Sci; 2021 Jun; 110(6):2346-2354. PubMed ID: 33684397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Li L; Liang Y; Hu F; Yan H; Li Y; Xie Z; Huang L; Zhao J; Wan Z; Wang H; Shui J; Cai W; Tang S
    Virology; 2020 Dec; 551():26-35. PubMed ID: 33011520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19).
    Huang F; Li Y; Leung EL; Liu X; Liu K; Wang Q; Lan Y; Li X; Yu H; Cui L; Luo H; Luo L
    Pharmacol Res; 2020 Aug; 158():104929. PubMed ID: 32442720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
    Kumar S; Zhi K; Mukherji A; Gerth K
    Viruses; 2020 Apr; 12(5):. PubMed ID: 32357553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Truvian Easy Check COVID-19 IgM/IgG Lateral Flow Device for Rapid Anti-SARS-CoV-2 Antibody Detection.
    Chan CW; Shahul S; Coleman C; Tesic V; Parker K; Yeo KJ
    Am J Clin Pathol; 2021 Feb; 155(2):286-295. PubMed ID: 33135049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.
    Bwire GM; Njiro BJ; Mwakawanga DL; Sabas D; Sunguya BF
    J Med Virol; 2021 Mar; 93(3):1361-1369. PubMed ID: 33090535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
    Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
    BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.
    Deinhardt-Emmer S; Wittschieber D; Sanft J; Kleemann S; Elschner S; Haupt KF; Vau V; Häring C; Rödel J; Henke A; Ehrhardt C; Bauer M; Philipp M; Gaßler N; Nietzsche S; Löffler B; Mall G
    Elife; 2021 Mar; 10():. PubMed ID: 33781385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
    Delorme-Axford E; Klionsky DJ
    Autophagy; 2020 Dec; 16(12):2123-2127. PubMed ID: 33153403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospects of Neutralizing Nanobodies Against SARS-CoV-2.
    Chen F; Liu Z; Jiang F
    Front Immunol; 2021; 12():690742. PubMed ID: 34122456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections.
    Parray HA; Shukla S; Perween R; Khatri R; Shrivastava T; Singh V; Murugavelu P; Ahmed S; Samal S; Sharma C; Sinha S; Luthra K; Kumar R
    Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6315-6332. PubMed ID: 34423407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.